Literatur
- 1
Karvonen M, Viik-Kajander M, Moltchanova E. et al .
Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project
Group.
Diabetes Care.
2000;
23
1516-1526
- 2
Green A, Patterson C C.
Trends in the incidence of childhood-onset diabetes in Europe 1989-1998.
Diabetologia.
2001;
44 (Suppl 3)
B 3-B 8
- 3
Ziegler A G, Hillebrand B, Rabl W. et al .
On the appearance of islet associated autoimmunity in offspring of diabetic mothers:
a prospective study from birth.
Diabetologia.
1993;
36
402-408
- 4
Rewers M, Bugawan T L, Norris J M. et al .
Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study
in the young (DAISY).
Diabetologia.
1996;
39
807-812
- 5
Kupila A, Muona P, Simell T. et al .
Feasibility of genetic and immunological prediction of type I diabetes in a population-based
birth cohort.
Diabetologia.
2001;
44
290-297
- 6
Ziegler A G, Hummel M, Schenker M. et al .
Autoantibody appearance and risk for development of childhood diabetes in offspring
of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study.
Diabetes.
1999;
48
460-468
- 7
Kimpimaki T, Kupila A, Hamalainen A M. et al .
The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible
children from the general population: the Finnish Type 1 Diabetes Prediction and Prevention
Study.
J Clin Endocrinol Metab.
2001;
86
4782-4788
- 8
Hummel M, Bonifacio E, Schmid S. et al .
Brief communication: early appearance of islet autoantibodies predicts childhood type
1 diabetes in offspring of diabetic parents.
Ann Intern Med.
2004;
140
882-886
- 9
Walter M, Albert E, Conrad M. et al .
IDDM2 / insulin VNTR modifies risk conferred by IDDM1 / HLA for development of Type
1 diabetes and associated autoimmunity.
Diabetologia.
2003;
46
712-720
- 10
Achenbach P, Koczwara K, Knopff A. et al .
Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade
that leads to type 1 diabetes.
J Clin Invest.
2004;
114
589-597
- 11
Schlosser M, Koczwara K, Kenk H. et al .
In insulin-autoantibody-positive children from the general population, antibody affinity
identifies those at high and low risk.
Diabetologia.
2005;
48
1830-1832
- 12
Mayr A, Schlosser M, Grober N. et al .
GAD Autoantibody affinity and epitope specificity identify distinct immunization profiles
in children at risk for type 1 diabetes.
Diabetes.
2007;
(Epub Feb 26)1
1
- 13
Gillespie K M, Gale E A, Bingley P J.
High familial risk and genetic susceptibility in early onset childhood diabetes.
Diabetes.
2002;
51
210-214
- 14
Schenker M, Hummel M, Ferber K. et al .
Early expression and high prevalence of islet autoantibodies for DR3 / 4 heterozygous
and DR4 / 4 homozygous offspring of parents with type I diabetes: the German BABYDIAB
study.
Diabetologia.
1999;
42
671-677
- 15
Pugliese A, Zeller M, Fernandez Jr A. et al .
The insulin gene is transcribed in the human thymus and transcription levels correlated
with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes.
Nat Genet.
1997;
15
293-297
- 16
Ziegler A G, Schmid S, Huber D. et al .
Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies.
Jama.
2003;
290
1721-1728
- 17
Redondo M J, Yu L, Hawa M. et al .
Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and
the United States.
Diabetologia.
2001;
44
354-362
- 18
Bonifacio E, Hummel M, Walter M. et al .
IDDM1 and multiple family history of type 1 diabetes combine to identify neonates
at high risk for type 1 diabetes.
Diabetes Care.
2004;
27
2695-2700
- 19
Achenbach P, Ziegler A G.
Diabetes-related antibodies in euglycemic subjects.
Best Pract Res Clin Endocrinol Metab.
2005;
19
101-117
- 20
Bingley P J, Christie M R, Bonifacio E. et al .
Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive
relatives.
Diabetes.
1994;
43
1304-1310
- 21
Krischer J P, Cuthbertson D D, Yu L. et al .
Screening strategies for the identification of multiple antibody-positive relatives
of individuals with type 1 diabetes.
J Clin Endocrinol Metab.
2003;
88
103-108
- 22
Achenbach P, Warncke K, Reiter J. et al .
Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics.
Diabetes.
2004;
53
384-392
- 23
Schlosser M, Strebelow M, Wassmuth R. et al .
The Karlsburg type 1 diabetes risk study of a normal schoolchild population: association
of beta-cell autoantibodies and human leukocyte antigen-DQB1 alleles in antibody-positive
individuals.
J Clin Endocrinol Metab.
2002;
87
2254-2261
- 24
Keymeulen B, Vandemeulebroucke E, Ziegler A G. et al .
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.
N Engl J Med.
2005;
352
2598-2608
- 25
Skyler J S, Krischer J P, Wolfsdorf J. et al .
Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes
Prevention Trial - Type 1.
Diabetes Care.
2005;
28
1068-1076
Prof. Dr. med. A.-G. Ziegler
3. Medizinische Abteilung · Städtisches Klinikum München GmbH · Klinikum Schwabing
Kölner Platz 1
80804 München
Email: anziegler@lrz.uni-muenchen.de
